From professional translators, enterprises, web pages and freely available translation repositories.
bisfosfonat, kodiċi atc:
bisphosphonate, atc code:
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
is- sustanza attiva f’ bondenza, aċidu ibandroniku huwa bisfosfonat.
the active substance in bondenza, ibandronic acid, is a bisphosphonate.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
is-sustanza attiva f’aclasta, l-aċidu zoledroniku, hija bisfosfonat.
the active substance in aclasta, zoledronic acid, is a bisphosphonate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
parti minnhom reġgħu ħarġulhom is-sintomi meta reġgħu ngħataw zoledronic acid jew bisfosfonat ieħor.
a subset had recurrence of symptoms when rechallenged with zoledronic acid or another bisphosphonate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
is-sustanza attiva f’ibandronic acid teva, l-aċidu ibandroniku, huwa bisfosfonat.
the active substance in ibandronic acid teva, ibandronic acid, is a bisphosphonate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
aċidu alendroniku huwa bisfosfonat li ilu jintuża għall-osteoporożi sa min-nofs id-disgħinijiet.
alendronic acid is a bisphosphonate that has been used for osteoporosis since the mid-1990s.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
is-sustanza attiva f’zoledronic acid teva pharma, l-aċidu żoledroniku, hija bisfosfonat.
the active substance in zoledronic acid teva pharma, zoledronic acid, is a bisphosphonate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
qabel kienu kkurati bisfosfonat (użati biex jittrattaw jew jipprevjenu d-disturbi fl-għadam).
have previously been treated with a bisphosphonate (used to treat or prevent bone disorders).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sottosett kellu rikorrenza tas-sintomi meta kien iċċalinġjat mill-ġdid bl-istess mediċina jew bi bisfosfonat ieħor.
a subset had recurrence of symptoms when rechallenged with the same drug or another bisphosphonate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kategorija farmakoterapewtika: prodotti mediċinali għattrattament ta’ mard fl-għadam, bisfosfonat, kodiċi atc: m05ba06.
pharmaco-therapeutic group: medicinal products for treatment of bone diseases, bisphosphonate, atc code: m05ba06.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kategorija farmakoterapewtika: prodotti mediċinali għa trattament ta’ mard fl-għadam, bisfosfonat, kodiċi atc: m05ba06.
pharmaco-therapeutic group: medicinal products for treatment of bone diseases, bisphosphonate, atc code: m05ba06.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kategorija farmakoterapewtika: prodotti mediċinali għall-kura ta’ disturbi fl-għadam, bisfosfonat, kodiċi atc: m05ba06
pharmaco-therapeutic group: medicinal products for treatment of bone diseases, bisphosphonate, atc code: m05ba06
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kwalunkwe bisfosfonat ieħor, minħabba li l-effetti kkombinati ta’ dawn il-mediċini meħudin flimkien ma’ zoledronic acid teva mhumiex magħruf.
any bisphosphonate medicine, since the combined effects of these medicines taken together with zoledronic acid teva are unknown.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
a il-proporzjon ta' periklu u l-valur p ibbażati fuq il-mudell cox aġġustat għall-psa (ln) u ldh (ln) u mqassam skont l-użu tal-bisfosfonat, in-numru ta' metastasi fl-għadam, u l-grad primarju ta' gleason. b il-proporzjon ta' periklu bbażat fuq il-mudell cox mhux aġġustat. c il-valur p ibbażat fuq test log-rank.
a hazard ratio and p-value based on the cox model adjusted for psa (ln) and ldh (ln) and stratified by bisphosphonate use, number of bone metastases, and primary gleason grade. b hazard ratio based on the unadjusted cox model. c p-value based on a log-rank test.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: